Position in RCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$42,039
-$433,323 QoQ
Shares Held
10,179
-89.1% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 73 holders
Holding Since
Mar 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $195,893,696 across 48 Medical Devices names. RCEL ranks #38 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
1,507,089 | $64,322,558 | |
| 2 | MDT |
Medtronic plc
|
381,816 | $29,869,465 | |
| 3 | ESTA |
Establishment Labs Holdings Inc.
|
235,980 | $20,249,443 | |
| 4 | TMDX |
TransMedics Group, Inc.
|
165,106 | $10,966,340 | |
| 5 | BRKR |
Bruker Corp
|
147,460 | $9,672,478 | |
| 6 | SNN |
Smith & Nephew PLC
|
281,007 | $8,095,811 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
97,904 | $6,266,835 | |
| 8 | NVCR |
NovoCure Ltd
|
392,319 | $5,943,632 |
All Filings in RCEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,039 | 10,179 | Shares | Defined | 2026-08-14 | |
| 2025-09-30 | $475,362 | 93,026 | Shares | Defined | 2025-11-14 | |
| 2023-03-31 | $160,962 | 11,522 | Shares | Defined | 2023-05-12 | |
| 2022-03-31 | $135,603 | 15,991 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||